Impel Pharmaceuticals (IMPL) Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Impel Pharmaceuticals (NASDAQ:IMPL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$55,148.21
Get IMPL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Impel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IMPL Insider Buying and Selling by Quarter

Impel Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/18/2023Vivo Capital Viii, LlcMajor ShareholderSell237,711$0.11$26,148.21  
12/15/2023Vivo Capital Viii, LlcMajor ShareholderSell100,000$0.29$29,000.00  
(Data available from 1/1/2013 forward)

IMPL Insider Trading Activity - Frequently Asked Questions

Who is on Impel Pharmaceuticals's Insider Roster?

The list of insiders at Impel Pharmaceuticals includes Adrian Adams, Timothy S Nelson, and Vivo Capital Viii, Llc. Learn more on insiders at IMPL.

What percentage of Impel Pharmaceuticals stock is owned by insiders?

6.20% of Impel Pharmaceuticals stock is owned by insiders. Learn more on IMPL's insider holdings.

Which Impel Pharmaceuticals insiders have been selling company stock?

The following insider sold IMPL shares in the last 24 months: Vivo Capital Viii, Llc ($55,148.21).

How much insider selling is happening at Impel Pharmaceuticals?

Insiders have sold a total of 337,711 Impel Pharmaceuticals shares in the last 24 months for a total of $55,148.21 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:IMPL) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners